Smith-Lemli-Opitz syndrome digital illustration

Smith-Lemli-Opitz syndrome Save


ICD-10 code: E78.72

Disease category: E78.7: Disorders of bile acid and cholesterol metabolism

Smith-Lemli-Opitz Syndrome (SLOS) is a rare genetic disorder characterized by a deficiency of the enzyme 7-dehydrocholesterol reductase (DHCR7), which plays a critical role in the synthesis of cholesterol. SLOS can cause a range of physical and developmental abnormalities, including intellectual disability, microcephaly, cleft palate, and distinctive facial features.

Cholesterol is a vital component of cell membranes and is necessary for many biological processes, including hormone production and vitamin D synthesis. Individuals with SLOS have abnormally low levels of cholesterol, which can lead to developmental delays, cognitive impairment, and physical abnormalities.

SLOS is caused by mutations in the DHCR7 gene, which is located on chromosome 11. The severity of the disorder can vary widely depending on the specific mutation and the degree of enzyme deficiency.

There is no cure for SLOS, and treatment is primarily focused on managing symptoms and complications. Cholesterol supplementation is often used to raise cholesterol levels, which can improve developmental outcomes and reduce the risk of complications such as liver and lung disease.

Other treatments may include physical therapy, occupational therapy, speech therapy, and special education to help manage developmental delays and cognitive impairment. Surgical interventions may be necessary to address physical abnormalities such as cleft palate.

Early diagnosis and intervention are critical for individuals with SLOS. Genetic testing can identify the underlying cause of the disorder, and early intervention can help improve developmental outcomes and reduce the risk of complications.

In conclusion, SLOS is a rare genetic disorder that can cause a range of physical and developmental abnormalities due to a deficiency in cholesterol synthesis. While there is no cure for SLOS, early diagnosis and intervention can help manage symptoms and improve developmental outcomes. Cholesterol supplementation is often used to raise cholesterol levels, and other treatments may include physical therapy, occupational therapy, speech therapy, special education, and surgical interventions.

Treatment of Smith-Lemli-Opitz syndrome:

Smith-Lemli-Opitz Syndrome (SLOS) is a rare genetic disorder that affects cholesterol metabolism. There is currently no cure for SLOS, but there are various treatments available to manage the symptoms and improve the quality of life for those affected by the disorder.

The primary treatment for SLOS involves the use of cholesterol supplementation. This treatment is aimed at increasing...

To see full information about treatment please Sign up or Log in